Carregant...
PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of PCSK9 inhibitors in the primary prevention of IHD in people with HeFH.
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491336/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012917 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|